The regulator of G-protein signaling RGS16 promotes insulin secretion and beta-cell proliferation in rodent and human islets
Indeed, the medication is intended as a tool for chronic weight management in the context of medical need, not a quick cosmetic fix
For instance, owners are often told to not let the dog do any slipping and sliding, twisting and turning, running and jumping, going up and down stairs etc
However, Ozempic is FDA-approved for specific uses in adults with type 2 diabetes and is not approved as a weight-loss medication
MSD's head of R&D, Dean Li, said that the licensing deal will "build on our experience targeting incretin biology to evaluate HS-10535 and its potential to provide additional cardiometabolic benefits beyond weight reduction." The company has a history in the incretin (gastrointestinal hormone) space with Januvia (sitagliptin), which targets DPP-4 and is a blockbuster treatment for type 2 diabetes, although it is now approaching the end of its patent life in the US and already seeing generic competition in other markets